Clinical Trials Directory

Trials / Unknown

UnknownNCT03268707

Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization

Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization And Quality of Life After Cryoballoon Pulmonary vEin Isolation in Patients With Paroxysmal Atrial Fibrillation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A randomized, open, mono-centric pilot study to investigate the influence of an innovative telemetric smartphone application on re-hospitalization and quality of life after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Detailed description

The telemetric smartphone application includes a digitized medical record, a mobile ECG device and a 24-hour on call service by a cardiologist. The hypothesis is that the use of a telemetric smartphone application can reduce re-hospitalization in patients after cryoballoon pulmonary vein isolation. Secondary endpoints are quality of life measurements, health care cost calculations and recurrences of atrial fibrillation after ablation. All patients will undergo ablation and will be randomized into two groups: 1) conventional follow up with outpatient visits 6 and 12 months after ablation compared to 2) a structured follow up with the smartphone application, a mobile ECG device (patients will be able to send in as many ECGs as wanted), up to three phone calls with a cardiologist (24-hour on call service) as well as outpatient visits 6 and 12 months after cryo-ablation.

Conditions

Interventions

TypeNameDescription
DEVICETelemetric smartphone applicationStructured follow up with a telemetric smartphone application
OTHERConventional follow upConventional follow up at physician practice

Timeline

Start date
2017-07-15
Primary completion
2020-12-31
Completion
2021-06-30
First posted
2017-08-31
Last updated
2019-06-18

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT03268707. Inclusion in this directory is not an endorsement.